Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
This study has been completed.
Information provided by (Responsible Party):
First received: May 18, 2002
Last updated: October 25, 2013
Last verified: October 2013
Comparative efficacy trial of INS365 Ophthalmic Solution and placebo in patients with dry eye.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||Double-Masked, Randomized, Placebo-Controlled Study of Efficacy Parameter Following Administration of INS365 Ophthalmic Solution or Placebo in a Controlled Adverse Environment (CAE) Chamber in Subjects With Non-Sjogren's Associated Dry Eye|
Resource links provided by NLM:
Further study details as provided by Merck:
Contacts and Locations